IL6 and type 1 diabetes mellitus: Interestingly, the expression of miR-342 has also been shown to be downregulated in the peripheral blood mononuclear cells of type 1 diabetic patients and inversely correlated with pro-inflammatory cytokine expression, including IL-6, IL-8, and TNF-α [78], suggesting its anti-inflammatory and potentially anti-atherogenic role.